Assessment of subclinical atherosclerosis to improve prevention of coronary artery disease

评估亚临床动脉粥样硬化以改善冠状动脉疾病的预防

• 批准号: nhmrc : GNT1169357
• 金额: $ 12.82万
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/assessment-subclinical-atherosclerosis-artery-disease/1379505
• 关键词: Assessment; subclinical; atherosclerosis; improve; prevention

To prevent heart disease, we currently treat many patients with statins based on their risk factors. Improving risk prediction by combining tests that identify pre-symptomatic disease (like other screening programs) can better identify those most likely to benefit from statins and save healthcare costs. This study aims to determine if this screening strategy is cost-effective and warrants a change to the current approach of primary prevention of coronary heart disease in Australia.

为了预防心脏病，我们目前根据患者的风险因素使用他汀类药物治疗许多患者。通过结合识别症状前疾病（如其他筛查计划）的测试来改善风险预测，可以更好地识别最有可能从他汀类药物中获益的人群，并节省医疗费用。本研究旨在确定这种筛查策略是否具有成本效益，并保证改变澳大利亚目前的冠心病一级预防方法。